Moderna and Merck’s Personalized mRNA Vaccine Reduces Melanoma Recurrence Risk by 42%
Moderna and Merck have announced results from a Phase 3 trial indicating that...
Browse Tag
Moderna
6 Articles
Personalized Cancer Vaccine Reduces Melanoma Recurrence Risk in Major Clinical Trial
A recent clinical trial has demonstrated that a new personalized cancer...
Misinformation Threatens Potential of mRNA Cancer Vaccines
A recent study shows that mRNA cancer vaccines, particularly a new personalized...
Moderna and Merck Announce Promising Advances in Cancer Vaccine Development
Moderna and Merck have reported significant progress in the development of...
FDA Reopens Review of Moderna’s mRNA Flu Shot
The Food and Drug Administration has reversed course and agreed to review...
FDA Rejects Moderna Application Over Clinical Trial Standards for mRNA Flu Vaccine
The Food and Drug Administration has declined to review an application from...
Technology
